Treatment abandonment in children with cancer: Does a sex difference exist? A systematic review and meta-analysis of evidence from low- and middle-income countries

Anna Palagyi, Christine Balane, Janani Shanthosh, Min Jun, Nirmala Bhoo-Pathy, Thomas Gadsden, Karen Canfell, Stephen Jan, Anna Palagyi, Christine Balane, Janani Shanthosh, Min Jun, Nirmala Bhoo-Pathy, Thomas Gadsden, Karen Canfell, Stephen Jan

Abstract

In this systematic review and meta-analyses, we sought to determine sex-disparities in treatment abandonment in children with cancer in low- and middle-income countries (LMICs) and identify the characteristics of children and their families most disadvantaged by such abandonment. Sex-disaggregated data on treatment abandonment were collated from the available literature and a random-effects meta-analysis was conducted to compare the rates in girls with those in boys. Subgroup analyses were conducted in which studies were stratified by design, cancer type and the Gender Inequality Index of the country of study. Eighteen studies were included in the systematic review and of these studies, 16 qualified for the meta-analysis, representing 10 754 children. The pooled rate of treatment abandonment overall was 30%. We observed no difference in the proportion of treatment abandonment in girls relative to estimates observed in boys (rate ratio [RR] 0.95, 95% CI: 0.79-1.15; P = .61). There was significant heterogeneity across the included studies and in the pooled estimate of RR for girls vs boys (both I2 > 98%). Subgroup analyses did not reveal any effect on abandonment risk. Risk factors for abandonment observed fell into three main categories: socio-demographic; geographic; and travel-related. In conclusion, a high rate of treatment abandonment (30%) was observed overall for children with cancer in included studies in LMICs, although this was variable and context specific. No evidence of gender bias in childhood cancer treatment abandonment rates across LMICs was found. Given that the risk factors for abandonment are context specific, in-depth country-level analyses may provide further insights into the role of a child's gender in treatment abandonment decisions.

Keywords: childhood cancer; low- and middle-income countries; sex differences; treatment abandonment.

© 2020 Union for International Cancer Control.

References

REFERENCES

    1. Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017;18:719-731.
    1. Child G, Collaborators AH. Diseases, injuries, and risk factors in Child and adolescent health, 1990 to 2017: findings from the global burden of diseases, injuries, and risk factors 2017 study. JAMA Pediatr. 2019;173:e190337-e190337.
    1. Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019;20:483-493.
    1. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28:2625-2634.
    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.
    1. Libes JM, Oruko OV, Abdallah FK, et al. Risk factors for abandonment of care for patients with wilms tumor in Kenya. Pediatr Blood Cancer. 2013;3:31.
    1. Friedrich P, Lam CG, Kaur G, Itriago E, Ribeiro RC, Arora RS. Determinants of treatment abandonment in childhood cancer: results from a global survey. PLoS One. 2016;11:e0163090.
    1. Friedrich P, Lam CG, Itriago E, Perez R, Ribeiro RC, Arora RS. Magnitude of treatment abandonment in childhood cancer. PLoS One. 2015;10:e0135230.
    1. Mostert S, Arora RS, Arreola M, et al. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC working group. Lancet Oncol. 2011;12:719-720.
    1. Mansell R, Purssell E. Treatment abandonment in children with cancer in sub-Saharan Africa: systematic literature review and meta-analysis. J Adv Nurs. 2018;74:800-808.
    1. Gupta S, Yeh S, Martiniuk A, et al. The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middle-income countries: a systematic review and meta-analysis. Eur J Cancer. 2013;49:2555-2564.
    1. Martijn HA, Njuguna F, Olbara G, et al. Influence of health insurance status on paediatric non-Hodgkin's lymphoma treatment in Kenya. BMJ Paediatrics Open. 2017;1:e000149.
    1. Mostert S, Njuguna F, van de Ven PM, et al. Influence of health-insurance access and hospital retention policies on childhood cancer treatment in Kenya. Pediatr Blood Cancer. 2014;61:913-918.
    1. Gupta S, Yeh S, Martiniuk A, et al. The magnitude and predictors of abandonment of therapy in pediatric acute leukemia in low-income and middle-income countries: a systematic review and meta-analysis. Pediatr Blood Cancer. 2012;59(6):1008.
    1. Mostert S, Gunawan S, Wolters E, et al. Socio-economic status plays important roles in childhood cancer treatment outcome in Indonesia. Asian Pac J Cancer Prev. 2012;13:6491-6496.
    1. Beattie A YR, Noble D. Accelerating progress towards universal health coverage for women and children in south asia, east asia and the pacific: UNICEF, 2016.
    1. Rodin R. Accelerating action towards universal health coverage by applying a gender lens. Bull World Health Organ. 2013;91:710-711.
    1. Ferlay J, Ervik M, Lam F, et al., eds. Cancer Today (Powered by GLOBOCAN 2018), International Agency for Research on Cancer CancerBase no. 15. Lyon, France: IARC; 2018.
    1. Bhopal SS, Mann KD, Pearce MS. Registration of cancer in girls remains lower than expected in countries with low/middle incomes and low female education rates. Br J Cancer. 2012;107:183-188.
    1. Pearce MS, Parker L. Childhood cancer registrations in the developing world: still more boys than girls. Int J Cancer. 2001;91:402-406.
    1. Agboola AO, Adekanmbi FA, Musa AA, et al. Pattern of childhood malignant tumours in a teaching hospital in South-Western Nigeria. MJA. 2009;190:12-14.
    1. Yaris N, Mandiracioglu A, Buyukpamukcu M. Childhood cancer in developing countries. Pediatr Hematol Oncol. 2004;21:237-253.
    1. Calu Costa J, Wehrmeister FC, Barros AJ, Victora CG. Gender bias in careseeking practices in 57 low- and middle-income countries. J Glob Health. 2017;7:010418.
    1. Gupta MD. Selective discrimination against female children in rural Punjab, India. Popul Dev Rev. 1987;13:77-100.
    1. Singh P, Singh N. The lesser child: a study of the interlinkages between Child sex ratios and discrimination against the girl Child in Punjab. Int J Punjab Stud. 2019;22:287-317.
    1. Ismail SA, McCullough A, Guo S, Sharkey A, Harma S, Rutter P. Gender-related differences in care-seeking behaviour for newborns: a systematic review of the evidence in South Asia. BMJ Glob Health. 2019;4:e001309.
    1. Institute of Medicine (US), National Research Council (US) National Cancer Policy Board. Findings and recommendations. In: Hewitt M, Simone JV, eds. Enhancing Data Systems to Improve the Quality of Cancer Care. Vol 6. Washington, DC: National Academies Press (US); 2000.
    1. Alam A, Kumar A. Impact of financial support and focussed group counselling on treatment abandonment in children with acute lymphoblastic leukaemia. Experience over 22 years from North India. Psychooncology. 2019;28:372-378.
    1. Cai J, Yu J, Zhu X, et al. Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group. Arch Dis Child. 2019;104:522-529.
    1. Klunder-Klunder M, Miranda-Lora AL, Dorantes-Acosta E, et al. Treatment abandonment in pediatric patients with acute lymphoblastic leukemia. Bol Med Hosp Infant Mex. 2012;69:226-232.
    1. Ramzan M, Yadav SP, Sachdeva A. Treatment abandonment is a major hurdle to improving survival in childhood cancer in the developing world. Pediatr Blood Cancer. 2013;60:159-160.
    1. Siddiqui DEF, Ashraf MS, Iftikhar S, Belgaumi AF. Predictors of treatment abandonment for patients with pediatric cancer at Indus children cancer hospital, Karachi. Pakistan Pediatr Blood Cancer. 2018;65:e26818.
    1. Stanley CC, van der Gronde T, Westmoreland KD, et al. Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer. 2018;26:967-973.
    1. Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007;49:941-946.
    1. Bhargav A, Singh U, Trehan A, Zadeng Z, Bansal D. Female sex, bilateral disease, age below 3 years, and apprehension for enucleation contribute to treatment abandonment in retinoblastoma. J Pediatr Hematol Oncol. 2017;39:e249-e253.
    1. Chitalkar PG, Rakesh T, Prashant K, Deepak S. Incidence and treatment abandonment in teen and young adult cancers. Natl J Med Res. 2016;6:77-79.
    1. Day S, McKeon L. Impact of nursing on treatment abandonment in children with cancer. Pediatr Blood Cancer. 2015;62(Suppl. 4):S195.
    1. Dua V, Yadav SP, Dinand V, et al. Sepsis and treatment abandonment are barriers to improving survival of children with relapsed acute lymphoblastic leukemia in the developing world. Pediatr Blood Cancer. 2011;57(5):737.
    1. Fawaz O. Treatment abandonment in pediatric cancer patients during wartime in Syria. Pediatr Blood Cancer. 2015;62(Suppl. 4):S204.
    1. Hong D, Zhou C, He H, Wang Y, Lu J, Hu S. A 10-year follow-up survey of treatment abandonment of children with acute myeloid Leukemia in Suzhou, China. J Pediatr Hematol Oncol. 2016;38:437-442.
    1. Ospina-Romero M, Portilla CA, Bravo LE, Ramirez O. Caregivers' self-reported absence of social support networks is related to treatment abandonment in children with cancer. Pediatr Blood Cancer. 2016;63:825-831.
    1. Jatia S, Arora B, Vora T, et al. Gender bias impacts cancer registration and treatment abandonment in children with cancer: time trends over three decades from India. Pediatr Blood Cancer. 2016;63(Suppl. 3):S89.
    1. Temmerman M, Khosla R, Laski L, Mathews Z, Say L. Women's health priorities and interventions. BMJ. 2015;351:h4147.
    1. Quick J, Jay J, Langer A. Improving women's health through universal health coverage. PLoS Med. 2014;11:e1001580.
    1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
    1. United Nations. Human Development Report 2019: Beyond Income, Beyond Averages, Beyond Today: Inequalities in Human Development in the 21st Century, 2019.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
    1. Critical Appraisal Skills Programme (2018). CASP Cohort Study Checklist. Available at: . Accessed 5 November 2019.
    1. Alam A, Kumar A. Prevalence, predictors, causes of treatment refusal and abandonment in children with acute lymphoblastic leukaemia over 18 years in North India. Treatment phase affecting factors: a step towards better focussed counselling. Cancer Epidemiol. 2018;57:53-59.
    1. Alvarez E, Seppa M, Rivas S, et al. Improvement in treatment abandonment in pediatric patients with cancer in Guatemala. Pediatr Blood Cancer. 2017;64. .
    1. Bonilla M, Rossell N, Salaverria C, et al. Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer. 2009;125:2144-2146.
    1. Friedrich P, Ortiz R, Strait K, et al. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement. Cancer. 2013;119:871-879.
    1. Kulkarni KP, Marwaha RK. Pattern and implications of therapy abandonment in childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2010;11:1435-1436.
    1. Kumar A, Moulik NR, Mishra RK, Kumar D. Causes, outcome and prevention of abandonment in retinoblastoma in India. Pediatr Blood Cancer. 2013;60:771-775.
    1. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet. 2003;362:706-708.
    1. Roy Moulik N, Kulkarni KP, Kumar A. Tracking children with acute lymphoblastic leukemia who abandoned therapy: experience, challenges, parental perspectives and impact of treatment subsidies and intensified counseling. Pediatr Hematol Oncol. 2016;33:327-337.
    1. Sitaresmi MN, Mostert S, Schook RM, Sutaryo VAJP. Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences. Psychooncology. 2010;19:361-367.
    1. Slone JS, Chunda-Liyoka C, Perez M, et al. Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia. PLoS One. 2014;9:e89102.
    1. Vasquez L, Diaz R, Chavez S, et al. Factors associated with abandonment of therapy by children diagnosed with solid tumours in Peru. Pediatr Blood Cancer. 2018;65:e27007.
    1. Wang YR, Jin RM, Xu JW, Zhang ZQ. A report about treatment refusal and abandonment in children with acute lymphoblastic leukemia in China, 1997-2007. Leuk Res. 2011;35:1628-1631.
    1. Williams LA, Spector LG. Survival differences between males and females diagnosed with childhood cancer. JNCI Cancer Spectrum. 2019;3:pkz032.
    1. Bonaventure A, Harewood R, Stiller CA, et al. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017;4:e202-e217.
    1. Hossain MJ, Xie L, McCahan SM. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. J Cancer Epidemiol. 2014;2014:865979.
    1. Cairo MS, Perkins SL. Hematological Malignancies in Children, Adolescents and Young Adultsed. Hackensack, NJ: World Scientific; 2012.
    1. Canfell K, Kim JJ, Brisson M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:591-603.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する